MetLife, Inc.
NYSEMET saw short interest surge 27% last week, reaching 14.12 million shares as of March 31. The jump marks the latest leg in a broader trend that has pushed short positions up 29.5% over the past month. Days to cover climbed to 3.67, up from 2.96 two weeks prior. This measure calculates how many trading days it would take short sellers to close their positions at recent volume levels. The increase reflects both growing short interest and relatively thin trading. Cost to borrow remains modest at 0.47%, though it has ticked up 31% from month-ago levels. Utilization sits at just 0.43%, well below the 52-week high of 2.76%. Plenty of shares remain available to borrow. MetLife shares closed at $77.48 on April 21, up 1.9% for the week and 13% for the month. The stock has rallied even as short sellers have increased their positions. Put/call ratio stands at 1.59, below its 20-day average of 1.63. Options traders appear slightly less bearish than recent norms, with the ratio sitting in the middle of its 52-week range. The insurer reports earnings April 30. Previous quarters have seen estimates announced in October, January, and February. MetLife operates in the life and health insurance sector. Short interest relative to float is not available due to missing float data. The current short position represents roughly 0.3% of the company's outstanding shares based on typical institutional ownership patterns for large-cap insurers. This is not financial advice. ORTEX data may contain errors.
Short Sellers Ramp Up MetLife Bets
MET saw short interest surge 27% last week, reaching 14.12 million shares as of March 31. The jump marks the latest leg in a broader trend that has pushed short positions up 29.5% over the past month. Days to cover climbed to 3.67, up from 2.96 two weeks prior. This measure calculates how many trading days it would take short sellers to close their positions at recent volume levels. The increase reflects both growing short interest and relatively thin trading. Cost to borrow remains modest at 0.47%, though it has ticked up 31% from month-ago levels. Utilization sits at just 0.43%, well below the 52-week high of 2.76%. Plenty of shares remain available to borrow. MetLife shares closed at $77.48 on April 21, up 1.9% for the week and 13% for the month. The stock has rallied even as short sellers have increased their positions. Put/call ratio stands at 1.59, below its 20-day average of 1.63. Options traders appear slightly less bearish than recent norms, with the ratio sitting in the middle of its 52-week range. The insurer reports earnings April 30. Previous quarters have seen estimates announced in October, January, and February. MetLife operates in the life and health insurance sector. Short interest relative to float is not available due to missing float data. The current short position represents roughly 0.3% of the company's outstanding shares based on typical institutional ownership patterns for large-cap insurers. This is not financial advice. ORTEX data may contain errors.
MetLife announced on August 5, 2026 a $3 billion equity buyback program. The authorization allows the company to repurchase its own shares up to that dollar limit — no shares have necessarily been bought yet. For…
MetLife authorized a share repurchase program on August 5, 2026. The announcement covers a buyback plan — an authorization to repurchase the company's own shares. An authorization is not a purchase; it gives the…
Snapshot as of 13 Aug 2026
MetLife reports Q2 results today with options traders showing the most defensive positioning in weeks — even as the analyst community remains uniformly bullish. The clearest signal heading into the print is in options.…
MetLife enters its August 5 earnings report on the back of a remarkable analyst consensus shift — one that has yet to be fully tested by the numbers. The Street has moved decisively bullish in recent weeks. JP Morgan…
MET heads into its August 5 earnings report with one of the cleanest analyst upgrade cycles in the insurance sector this summer — ten firms lifting price targets in under three weeks, and the stock still trading below…
MetLife heads into the final stretch before its August 5 earnings print with the Street actively upgrading its view and the stock trading at a six-month high. The analyst activity this week has been unusually…
MetLife enters the back half of June having quietly outrun most of its life-insurance peers this week, with the stock up 0.7% to $88.03 while the closest comparables PRU and UNM slipped into the red. The more…
MetLife reports second-quarter results on June 16 against a backdrop of unusual momentum: the stock has climbed 13% over the past month to $88.84, and the Street has spent the last several weeks upgrading its view of…
MetLife enters its next reporting cycle with the Street upgrading price targets and short sellers quietly rebuilding positions — a combination that makes this week's price action worth watching closely. The analyst…
MET reports Q1 2026 results today having done something unusual in a volatile spring market — rallied 13% in a month to close at $80.16. The price move is the standout. MET gained 13.3% over the past month, dwarfing…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for MET — free to start on ORTEX.
Sign up for free →Open MET on ORTEX